Articles tagged with 'weight management' | Cedars-Sinai Medical Center

A new class of medications called GLP-1s (glucagon-like peptide-1 receptor agonists) have been grabbing headlines for their dramatic results in helping people shed stubborn pounds, thereby controlling diabetes as well as reducing their risk of heart …

Investigators at Cedars-Sinai and other institutions conducted a nationwide, population-based study to identify trends in the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs)—prescription medications sold under popular drug names like …

New research from Cedars-Sinai suggests people who are scheduled for certain medical procedures should stop taking popular weight loss drugs in the days or weeks prior to avoid complications.Investigators found glucagon-like peptide-1 receptor …

Oprah Winfrey recently interviewed Amanda Velazquez, MD, director of Obesity Medicine in the Department of Surgery at Cedars-Sinai, about the global impact new prescription weight loss medications are having on healthcare, the …

Amanda Velazquez, MD, director of Obesity Medicine in the Department of Surgery at Cedars-Sinai, recently was featured in a WebMD webinar about obesity, the challenges of shedding pounds and maintaining a healthy weight. Obesity is a chronic …

WHAT:The science is unclear on exactly why an increasingly popular new class of federally approved diabetes and obesity medications work, but they do know that they are effective at helping people lose weight. The medications are sold under brand …